BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21920136)

  • 1. Part V. Surveillance activities.
    Bamford C; Brink A; Govender N; Lewis DA; Perovic O; Botha M; Harris B; Keddy KH; Gelband H; Duse AG
    S Afr Med J; 2011 Jul; 101(8 Pt 2):579-82. PubMed ID: 21920136
    [No Abstract]   [Full Text] [Related]  

  • 2. Part VII. Interventions.
    Visser A; Moore DP; Whitelaw A; Lowman W; Kantor G; Hoosen A; Madhi S; Brink A; van den Bergh D; Devenish L; Moodley P; Apalata T; Duse AG; Gelband H
    S Afr Med J; 2011 Jul; 101(8 Pt 2):587-95. PubMed ID: 21920138
    [No Abstract]   [Full Text] [Related]  

  • 3. Part IV. Human infections and antibiotic resistance.
    Crowther-Gibson P; Govender N; Lewis DA; Bamford C; Brink A; von Gottberg A; Klugman K; du Plessis M; Fali A; Harris B; Keddy K; Botha M
    S Afr Med J; 2011 Jul; 101(8 Pt 2):567-78. PubMed ID: 21920135
    [No Abstract]   [Full Text] [Related]  

  • 4. Communicable diseases surveillance. National Notifiable Diseases Surveillance System.
    Commun Dis Intell Q Rep; 2010 Dec; 34(4):459-77. PubMed ID: 21413533
    [No Abstract]   [Full Text] [Related]  

  • 5. Part III. Antibiotic supply chain and management in human health.
    Essack SY; Schellack N; Pople T; van der Merwe L; Suleman F; Meyer JC; Gous AG; Benjamin D
    S Afr Med J; 2011 Jul; 101(8 Pt 2):562-6. PubMed ID: 21920134
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance data in CDI.
    Commun Dis Intell; 1998 Jan; 22(1):4-8. PubMed ID: 9503743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part I. the Global Antibiotic Resistance Partnership (GARP).
    Winters C; Gelband H
    S Afr Med J; 2011 Jul; 101(8 Pt 2):556-7. PubMed ID: 21920132
    [No Abstract]   [Full Text] [Related]  

  • 8. Strengthening infectious disease surveillance in Europe.
    Lancet Infect Dis; 2008 Sep; 8(9):525. PubMed ID: 18718435
    [No Abstract]   [Full Text] [Related]  

  • 9. A foresight vision for infectious diseases in Africa.
    Brownlie J
    Onderstepoort J Vet Res; 2012 Jun; 79(2):459. PubMed ID: 23327379
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infectious diseases risk management].
    Salomon J; Guillemot D; Bernard L; Perronne C
    Rev Prat; 2005 Nov; 55(18):2003-13. PubMed ID: 16419905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive summary: global antimicrobial resistance alerts and implications.
    Alliance for the Prudent Use of Antibiotics
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S221-3. PubMed ID: 16032555
    [No Abstract]   [Full Text] [Related]  

  • 12. Making use of electronic data: the National Healthcare Safety Network eSurveillance Initiative.
    Edwards JR; Pollock DA; Kupronis BA; Li W; Tolson JS; Peterson KD; Mincey RB; Horan TC
    Am J Infect Control; 2008 Apr; 36(3 Suppl):S21-6. PubMed ID: 18374208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating infectious diseases in the Pacific Islands: sentinel surveillance, environmental health, and geospatial tools.
    Lau C
    Rev Environ Health; 2014; 29(1-2):113-7. PubMed ID: 24566353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report from the Communicable Diseases Network Australia, January to March 2004.
    Commun Dis Intell Q Rep; 2004; 28(2):277-8. PubMed ID: 15460971
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious diseases pose new pressures but provide new opportunities for health care.
    Simmons JC
    Qual Lett Healthc Lead; 2000 Mar; 12(3):2-11, 1. PubMed ID: 10947530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part VI. Antibiotic management and resistance in livestock production.
    Henton MM; Eagar HA; Swan GE; van Vuuren M
    S Afr Med J; 2011 Jul; 101(8 Pt 2):583-6. PubMed ID: 21920137
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent changes in the epidemiology of infectious diseases in the Netherlands: the report 'Status of infectious diseases in the Netherlands, 2000-2005'].
    Rahamat-Langendoen JC; van Vliet JA
    Ned Tijdschr Geneeskd; 2007 Jun; 151(24):1333-8. PubMed ID: 17665624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing countries must balance access to antibiotics with action to curb resistance.
    Mudur G
    BMJ; 2011 Oct; 343():d6471. PubMed ID: 21984817
    [No Abstract]   [Full Text] [Related]  

  • 19. Report calls for $2bn global fund to kickstart antibiotic development.
    Wise J
    BMJ; 2015 May; 350():h2635. PubMed ID: 25975228
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infectious diseases in the global days. Present situation in Japan--infectious disease surveillance].
    Okabe N
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():9-15. PubMed ID: 12722186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.